Clinical Trial Update: Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ticagrelor in patients undergoing percutaneous coronary intervention for acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED